Skip to main content
. 2018 Jun;10(6):3319–3328. doi: 10.21037/jtd.2018.05.96

Table 2. Patient characteristics at the time of respiratory failure.

Characteristic      NIV success (n=69) NIV failure (n=43) P value
SOFA score 7.92±2.08 9.95±2.08 <0.0001
IABP, n (%) 1 (1.4) 4 (9.3) 0.137
CVVH, n (%) 2 (2.9) 4 (9.3) 0.311
Low cardiac output syndrome, n (%) 14 (20.3) 21 (48.8) 0.002
Renal failure, n (%) 12 (17.4) 17 (39.5) 0.011
Arrhythmia, n (%) 11 (15.9) 6 (14.0) 0.775
Laboratory test
   White blood cell count, ×109/L 14.1 (10.4–18.1) 14.1 (10.3–19.4) 0.613
   Platelet count, ×109/L 96 [60–169] 76 [35–103] 0.006
   Bilirubin, µmol/L 25.1 (16.3–45.0) 35.1 (19.8–70.8) 0.037
   Creatinine, µmol/L 94 [78–130] 119 [90–199] 0.033
Vasoactive-inotropic score 5.3±2.5 6.6±2.2 0.004
Respiratory rate, breaths/min 21.1±3.7 22.6±6.1 0.304
Heart rate, beats/min 104.0±25.2 104.2±14.2 0.952
Time elapsed since extubation, h 10.6 (4.8–27.6) 15.1 (1.92–30.0) 0.373
pH 7.48±0.24 7.41±0.07 0.083
PaCO2, mmHg 38.2±7.5 39.6±8.7 0.390
PaO2, mmHg 69 [63–83] 68 [56–88] 0.428

Data were presented as mean ± SD or median (interquartile range), categorical variables were presented as number (%). CVVH, continuous venovenous hemofiltration; h, hours; IABP, intra-aortic balloon pump; PaCO2, partial pressure of carbon dioxide in arterial blood; PaO2, partial pressure of oxygen in arterial blood; SOFA, Sequential Organ Failure Assessment. Vasoactive-inotropic score: dosages of dopamine + dobutamine (ìg/kg/min) + [dosages of epinephrine + norepinephrine + isoproterenol (ìg/kg/min)] ×100 + dosages of milrinone (ìg/kg/min) ×15.